BRISTOL REGIONAL MEDICAL CENTER
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $577K
- Transactions
- 405
- Companies
- 22
- Average per transaction
- $1,425
Who reported the payments
| Contego Medical, Inc | $216,906 |
| Medtronic | $91,275 |
| Tandem Diabetes Care, Inc. | $74,925 |
| Insulet Corporation | $71,075 |
| Incyte Corporation | $33,629 |
| Genentech, Inc. | $27,115 |
| Daiichi Sankyo Inc. | $25,086 |
| Stryker | $8,923 |
| Hill-rom Company, Inc | $8,203 |
| Medline Industries LP | $5,000 |
| Linvatec Corporation | $4,963 |
| CSL Behring | $3,000 |
| Eli Lilly | $1,780 |
| Abbott | $1,446 |
| Siemens Medical Solutions USA, Inc. | $1,351 |
| Organon | $700 |
| Bioventus LLC | $642 |
| Aesculap, Inc. | $389 |
| Hollister Incorporated | $368 |
| BD | $270 |
| Leica Microsystems Inc. | $139 |
| Merck | $6 |